Biotech Entrepreneurs Report to ‘Boot Camp’

Another great story from Bradley Fikes at UT-San Diego about entrepreneurs hitting the 2014 BIO Convention with big goals, big dreams -- and possibly big rewards: "The rewards of success can be tremendous -- billions of dollars in sales and the satisfaction of treating difficult illnesses and saving lives. Just as basic research is the [...]

June 23rd, 2014|

Ahead of BIO 2014, An Interview With Joe Panetta, president and CEO of Biocom

Ahead of BIO 2014, Daniel Levine of Levine Media Group/The Burrill Report, interviewed Joe Panetta, the president and CEO of the local trade association, Biocom. They cover the changes that have occurred in San Diego biotech since the last time the BIO convention was here, including some information on how financing, grant funding, and capital resources [...]

June 14th, 2014|

Pfenex Eyes a $75M IPO

From FierceBiotech: "San Diego biotech Pfenex has evolved from helping Big Pharma craft large-molecule therapies to developing biosimilars of its own, and now the company is looking to raise about $74.8 million to cash in on the coming boom in biologic knockoffs. The company, a spinoff of Dow Chemical, is using its proprietary protein expression technology to [...]

June 7th, 2014|

San Diego’s Ambrx Files for IPO

Recent coverage of San Diego biotech Ambrx filing its IPO: Xconomy: San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates More FierceBiotech: Bristol-Myers' armed antibody partner Ambrx shoots for an $86M IPO More UT San Diego (subscription): Ambrx files for IPO More

May 8th, 2014|

San Diego Life Sciences Roundup from Xconomy

Big highlight - VC investment for the first quarter of the year: "Venture capital firms pumped $243 million into 23 startup companies in the San Diego area during the first quarter that ended in March, according to data from the MoneyTree Report from PricewaterhouseCoopers, the National Venture Capital Association, and Thomson Reuters. About $178 million of [...]

April 30th, 2014|

Why we chose San Diego over Silicon Valley

In a post last week in the San Diego Daily Transcript, Stephan Goss, CEO of Zeeto Media, and Jeff Brice, CEO of TrustEgg, detail why they chose San Diego over Silicon Valley for their businesses -- maybe there are aspects that biotech entrepreneurs should consider as well. Some excerpts: - "Forbes recently named San Diego the No. [...]

April 14th, 2014|

San Diego: Where biotech is booming…and there’s no snow

U-T San Diego columnists Barbara Bry and Neil Senturia have a Q&A feature with Joe Panetta, CEO of Biocom, who discusses the growth of San Diego biotech industry and what it needs to do to continue its success. One of the more interesting aspects from the interview (especially in regards to the "Big 3"): "Q: Who [...]

April 1st, 2014|

March Financial Recap

Biotech stocks dropped sharply across the country towards the end of the month, and San Diego-area companies felt it too - a big reversal on what had been a continual bull market. More on that here. One of the biggest news items earlier in the month was JC Venter’s big news of raising $70M to fund [...]

March 28th, 2014|